| abstract |
The present invention relates to a compound of formula (I) or a pharmaceutically acceptable solvate or salt thereof, a compound comprising solvates of such salts,n n n (Ⅰ)n n n Wherein R 1 is such that the compound of formula (I) is a prodrug of 1R, 2S-methoxamine that is converted into the active form or an active metabolite thereof in the renal tubule. The compounds serve specific uses in the prevention and treatment of urinary incontinence. |